Literature DB >> 23021972

Thromboembolic events following surgery for prostate cancer.

Mieke Van Hemelrijck1, Hans Garmo, Lars Holmberg, Anna Bill-Axelson, Stefan Carlsson, Olof Akre, Pär Stattin, Jan Adolfsson.   

Abstract

BACKGROUND: Prostate cancer (PCa) and surgery are both associated with increased risk of thromboembolic diseases (TED).
OBJECTIVE: We assessed risk of TED among men undergoing different types of urologic surgery. DESIGN, SETTING, AND PARTICIPANTS: Using the Prostate Cancer Database Sweden (PCBaSe) Sweden, we identified all men (n=45 065) undergoing pelvic lymph node dissection (PLND), radical prostatectomy (RP) with or without PLND, orchiectomy due to PCa, or a transurethral resection of the prostate (TURP). We identified a comparison cohort from the population. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: Main outcomes were deep venous thrombosis (DVT) and pulmonary embolism (PE) as primary diagnoses in the National Patient Register or Cause of Death Register (2002-2010). We calculated hazard ratios (HR) and 95% confidence intervals (CI) using multivariable Cox proportional hazards models. RESULTS AND LIMITATIONS: All surgical procedures were associated with increased risk of TED; laparoscopic and open RP with a PLND were the most strongly associated with TED (HR for PE: 8.1 [95% CI, 2.9-23.0] and 7.8 [95% CI, 4.9-13], respectively). For surgery including a PLND, the risk increased during the second half of the first postoperative month. The HR for PE after TURP in men with PCa was 3.0 (95% CI, 1.8-5.1). Patients with a history of TED had a strongly increased risk of TED (HR for DVT: 4.5; 95% CI, 2.6-8.0). A limitation is lack of information on TED prophylaxis, but its use was standardized during the study period for RP and PLND. Other limitations are lack of information on extent of PLND and lifestyle factors.
CONCLUSIONS: Surgeries for PCa, including TURP, are associated with hospitalization for TED. Patients with a history of TED and patients undergoing a PLND were at highest risk. The largest risk was observed from days 14 to 28 postoperatively. Thus, our results suggest that prophylactic measures may be beneficial during the first 4 wk in these patients.
Copyright © 2012 European Association of Urology. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23021972     DOI: 10.1016/j.eururo.2012.09.041

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  7 in total

Review 1.  Reducing morbidity of pelvic and retroperitoneal lymphadenectomy.

Authors:  Mark W Ball; Michael A Gorin; Mohamad E Allaf
Journal:  Curr Urol Rep       Date:  2013-10       Impact factor: 3.092

2.  Perioperative changes in pro and anticoagulant factors in prostate cancer patients undergoing laparoscopic and robotic radical prostatectomy with different anaesthetic techniques.

Authors:  Maria Sofra; Anna Antenucci; Michele Gallucci; Chiara Mandoj; Rocco Papalia; Claudia Claroni; Ilaria Monteferrante; Giulia Torregiani; Valeria Gianaroli; Isabella Sperduti; Luigi Tomao; Ester Forastiere
Journal:  J Exp Clin Cancer Res       Date:  2014-08-17

Review 3.  Influence of steep Trendelenburg position on postoperative complications: a systematic review and meta-analysis.

Authors:  Satoshi Katayama; Keiichiro Mori; Benjamin Pradere; Takafumi Yanagisawa; Hadi Mostafaei; Fahad Quhal; Reza Sari Motlagh; Ekaterina Laukhtina; Nico C Grossmann; Pawel Rajwa; Abdulmajeed Aydh; Frederik König; Pierre I Karakiewicz; Motoo Araki; Yasutomo Nasu; Shahrokh F Shariat
Journal:  J Robot Surg       Date:  2021-12-31

4.  Risk of venous thromboembolism in men with prostate cancer compared with men in the general population: a nationwide population-based cohort study in Sweden.

Authors:  Yanina Balabanova; Bahman Farahmand; Hans Garmo; Pär Stattin; Gunnar Brobert
Journal:  BMJ Open       Date:  2022-05-23       Impact factor: 3.006

Review 5.  Robot assisted lymphadenectomy in urology: pelvic, retroperitoneal and inguinal.

Authors:  Giovannalberto Pini; Surena F Matin; Nazareno Suardi; Mihir Desai; Inderbir Gill; James Porter; Robert J Stein; Rene Sotelo; Franco Gaboardi; Francesco Porpiglia
Journal:  Minerva Urol Nefrol       Date:  2016-11-08

6.  Venous thromboembolism prophylaxis in patients undergoing abdominal and pelvic cancer surgery: adherence and compliance to ACCP guidelines in DIONYS registry.

Authors:  Melkart Basile; Maroon Tohmeh; Negib Geahchan
Journal:  Springerplus       Date:  2016-09-13

7.  Population-based study of long-term anticoagulation for treatment and secondary prophylaxis of venous thromboembolism in men with prostate cancer in Sweden.

Authors:  Yanina Balabanova; Bahman Farahmand; Pär Stattin; Hans Garmo; Gunnar Brobert
Journal:  BMC Urol       Date:  2022-02-02       Impact factor: 2.264

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.